Korean J Ophthalmol.  2010 Feb;24(1):35-39. 10.3341/kjo.2010.24.1.35.

Differential Expression of Stem Cell Markers and Vascular Endothelial Growth Factor in Human Retinoblastoma Tissue

Affiliations
  • 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. ysyu@snu.ac.kr
  • 2Seoul Artificial Eye Center, Seoul National University Hospital Clinical Research Institute, Seoul, Korea.
  • 3Department of Radiology, Soonchunhyang University College of Medicine, Bucheon, Korea.

Abstract

PURPOSE: To investigate the relationship between vascular endothelial growth factor (VEGF) and the cancer stem cell-vascular niche complex in human retinoblastoma tissue.
METHODS
Six human retinoblastoma specimens primarily enucleated for Reese-Ellsworth classification stage 5a were stained to detect cancer stem cell markers, including ABCG2 for the stem cell marker and MCM2 for the neural stem cell marker, as well as to detect VEGF for the angiogenic cytokine. Using immunofluorescence, the expression of these proteins was analyzed, and their relative locations noted.
RESULTS
In non-neoplastic retina of tumor-bearing eyes, ABCG2 and MCM2 were sporadically expressed in the ganglion cell layer and the inner nuclear layer, whereas VEGF was sporadically expressed in inner retina where retinal vessels are abundantly distributed. In the tumor, ABCG2 was strongly expressed out of Wintersteiner rosettes, whereas MCM2 and VEGF were strongly stained in the rosettes. Interestingly, the outer portion of the rosettes was positive for MCM2, and the inner portion of the rosettes was positive for VEGF.
CONCLUSIONS
Our data demonstrated that MCM2 and VEGF are strongly expressed in the rosettes of the tumor, which were far from the area of ABCG2-positive cells. Although VEGF might not directly contribute to the cancer stem cell-vascular niche complex, it could play some role in the differentiation of tumor cells to build up the rosettes.

Keyword

Biological tumor markers; Neoplastic stem cells; Retinoblastoma; Vascular endothelial growth factors

MeSH Terms

ATP-Binding Cassette Transporters/metabolism
Biological Markers/*metabolism
Cell Cycle Proteins/metabolism
Fluorescent Antibody Technique
Humans
Neoplasm Proteins/metabolism
Nuclear Proteins/metabolism
Organ Specificity
Retina/metabolism
Retinal Neoplasms/*metabolism
Retinoblastoma/*metabolism
Stem Cells/*metabolism
Vascular Endothelial Growth Factor A/*metabolism

Figure

  • Fig. 1 ABCG2, MCM2, and VEGF expression in the non-neoplastic retina of the human retinoblastoma eye. (A) ABCG2 was sporadically expressed in the ganglion cell layer and the inner nuclear layer. Original magnification ×20. (B) MCM2 positivity was observed in GCL and INL, similar to ABCG2. Original magnification ×20. (C) VEGF was also sporadically expressed in the inner retina. Original magnification ×20. VEFG=vascular endothelial growth factor; GCL=ganglion cell layer; IPL=inner plexiform layer; INL=inner nuclear layer; OPL=outer plexiform layer; ONL=outer nuclear layer.

  • Fig. 2 ABCG2, MCM2, and VEGF expression in retinoblastoma tumors. (A and B) ABCG2 was expressed outside of the Wintersteiner rosettes or tumor lobules. (C and D) MCM2 was strongly expressed in the rosettes and lobules, especially in the outer portion of the rosettes. (E and F) VEGF positivity was also observed in the rosettes of lobules, specifically in the inner portion of the rosettes. Original magnification ×20 with A, C, and E. Original magnification ×40 with B, D, and F.


Reference

1. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med. 2007. 58:267–284.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001. 414:105–111.
3. Yilmaz OH, Valdez R, Theisen BK, et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006. 441:475–482.
4. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008. 8:290–301.
5. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007. 11:69–82.
6. Bao S, Wu Q, Sathornsumetee S, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res. 2006. 66:7843–7848.
7. Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2005. 46:2683–2691.
8. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer. 2005. 5:91–101.
9. Nork TM, Schwartz TL, Doshi HM, Millecchia LL. Retinoblastoma. Cell of origin. Arch Ophthalmol. 1995. 113:791–802.
10. Seigel GM, Hackam AS, Ganguly A, et al. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis. 2007. 13:823–832.
11. Mohan A, Kandalam M, Ramkumar HL, et al. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma. Br J Ophthalmol. 2006. 90:889–893.
12. Zhong X, Li Y, Peng F, et al. Identification of tumorigenic retinal stem-like cells in human solid retinoblastomas. Int J Cancer. 2007. 121:2125–2131.
13. Kvanta A, Steen B, Seregard S. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma. Exp Eye Res. 1996. 63:511–518.
14. Stitt AW, Simpson DA, Boocock C, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours. J Pathol. 1998. 186:306–312.
15. Apte RS, Harbour JW. Inhibiting angiogenesis in retinoblastoma. Ophthalmic Res. 2007. 39:188–190.
16. Jia RB, Zhang P, Zhou YX, et al. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma. Ophthalmic Res. 2007. 39:108–115.
17. Lee SY, Kim DK, Cho JH, et al. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma. Arch Ophthalmol. 2008. 126:953–958.
18. Seigel GM, Campbell LM, Narayan M, Gonzalez-Fernandez F. Cancer stem cell characteristics in retinoblastoma. Mol Vis. 2005. 11:729–737.
19. Litman T, Brangi M, Hudson E, et al. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci. 2000. 113:2011–2021.
20. Maslov AY, Barone TA, Plunkett RJ, Pruitt SC. Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. J Neurosci. 2004. 24:1726–1733.
21. Schlesinger HR, Rorke L, Jamieson R, Hummeler K. Neuronal properties of neuroectodermal tumors in vitro. Cancer Res. 1981. 41:2573–2575.
22. Pe'er J, Neufeld M, Baras M, et al. Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction. Ophthalmology. 1997. 104:1251–1258.
23. Grothey A, Ellis LM. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies. Cancer J. 2008. 14:170–177.
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr